Dacomitinib is designed to target the Epidermal Growth Factor Receptor, which is used to treat NSCLC. It’s made especially for people who have the EGFR 19 deletion or L858R mutation. It stops EGFR signals, which are crucial for cancer cell growth and life.
You’ve got three strengths: 15mg, 30mg, and 45mg. The doctor usually recommends 45mg, taken once every day. All the doses come as easy-to-swallow tablets with a coating.
Each bottle has 30 of those tablets.
Reviews
There are no reviews yet.